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Abstract: AIMS To evaluate the diagnosis and imaging of patients with suspected endocarditis and the
management in routine clinical practice across Europe, the EACVI Scientific Initiatives Committee per-
formed a survey across European centres. In particular, the routine use of echocardiography, advanced
imaging modalities and multidisciplinary team was explored. METHODS AND RESULTS A total of
100 European Echocardiography Laboratories from 29 different countries responded to the survey, which
consisted of 20 questions. For most of the use of echocardiography and advanced imaging, answers from
the centres were relatively homogeneous and demonstrated good adherence to current recommendations.
In particular, two-thirds of centres report the use of a specific endocarditis team for decision-making.
Echocardiography plays a key role in the diagnosis and management of endocarditis. Nuclear imaging
modalities are broadly available among the centres and are mainly used in prosthetic valve endocarditis
and cardiac device-related infective endocarditis. Computed tomography (CT) is widely available and
used to assess for structural valve abnormalities, neurological complications, and to preoperative assess-
ment of the coronary arteries. Most institutions provide structured patients follow-up following hospital
discharge. CONCLUSION In Europe, a relatively homogenous adherence to current recommendation
was observed for most diagnostic and management including the follow-up of patients with endocarditis.
Decision-making is most commonly performed by a multidisciplinary team. Echocardiography remains
the first line and central imaging modality for patient diagnosis and assessment, but 60% of centres also
commonly use CT, whilst positron emission tomography imaging is used in patients with prosthetic valve
endocarditis or device infection.
DOI: https://doi.org/10.1093/ehjci/jeaa066






The following work is licensed under a Creative Commons: Attribution 4.0 International (CC BY 4.0)
License.
Originally published at:
Holte, Espen; Dweck, Marc R; Marsan, Nina Ajmone; D’Andrea, Antonello; Manka, Robert; Stankovic,
Ivan; Haugaa, Kristina H (2020). EACVI survey on the evaluation of infective endocarditis. European




































EACVI survey on the evaluation of infective
endocarditis
Espen Holte 1,2*, Marc R. Dweck, Nina Ajmone Marsan, Antonello D’Andrea,
Robert Manka, Ivan Stankovic, and Kristina H. Haugaa
1Clinic of Cardiology, St. Olavs Hospital, PO Box 3250, Torgarden, 7006 Trondheim, Norway; and 2Department of Circulation and Medical Imaging, Norwegian University of
Science and Technology NTNU, Trondheim, PO Box 8905, 7491 Trondheim, Norway
Received 17 March 2020; editorial decision 19 March 2020; accepted 23 March 2020; online publish-ahead-of-print 3 May 2020
Aims To evaluate the diagnosis and imaging of patients with suspected endocarditis and the management in routine clin-
ical practice across Europe, the EACVI Scientific Initiatives Committee performed a survey across European





A total of 100 European Echocardiography Laboratories from 29 different countries responded to the survey,
which consisted of 20 questions. For most of the use of echocardiography and advanced imaging, answers from the
centres were relatively homogeneous and demonstrated good adherence to current recommendations. In particu-
lar, two-thirds of centres report the use of a specific endocarditis team for decision-making. Echocardiography
plays a key role in the diagnosis and management of endocarditis. Nuclear imaging modalities are broadly available
among the centres and are mainly used in prosthetic valve endocarditis and cardiac device-related infective endo-
carditis. Computed tomography (CT) is widely available and used to assess for structural valve abnormalities,
neurological complications, and to preoperative assessment of the coronary arteries. Most institutions provide
structured patients follow-up following hospital discharge.
...................................................................................................................................................................................................
Conclusion In Europe, a relatively homogenous adherence to current recommendation was observed for most diagnostic and
management including the follow-up of patients with endocarditis. Decision-making is most commonly performed
by a multidisciplinary team. Echocardiography remains the first line and central imaging modality for patient diagno-
sis and assessment, but 60% of centres also commonly use CT, whilst positron emission tomography imaging is
used in patients with prosthetic valve endocarditis or device infection.
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Introduction
Endocarditis is a serious and potentially life-threatening disease, rep-
resenting a significant burden to the health system. Despite optimal
care, mortality approaches 30% at 1 year. An accurate diagnostic
workflow is essential to help facilitate early detection and the initi-
ation of appropriate treatment. Both transthoracic (TTE) and trans-
oesophageal echocardiography (TOE) have a well-established role in
patients with endocarditis, but recently other imaging modalities
including computed tomography (CT) and positron emission tomog-
raphy (PET) have also demonstrated their utility.
European guidelines for the management of patients with endocar-
ditis have recently been updated1: the Task Force for the
Management of infective endocarditis of the European Society of
Cardiology (ESC), endorsed by European Association for Cardio-
Thoracic Surgery (EACTS) and the European Association of Nuclear
Medicine (EANM). This document aimed to provide clear and simple
recommendations, assisting healthcare providers in their clinical
decision-making in patients evaluated for endocarditis. This guideline
enhanced the role of PET and CT imaging for the detection of infec-
tious foci when echocardiography remains inconclusive and intro-
duced new diagnostic criteria that included these advanced imaging
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techniques to improve diagnostic sensitivity. However, there are con-
cerns about the availability of these imaging modalities across differ-
ent parts of Europe and more generally there remains a lack of
randomized controlled trials to guide practice in endocarditis.
The aim of this survey from the European Association of
Cardiovascular Imaging (EACVI) Scientific Initiatives Committee was
therefore to evaluate the diagnosis and imaging of patients with sus-
pected endocarditis and how they are managed in routine clinical
practice across Europe. The EACVI Scientific Initiatives Committee
network include imaging centres across Europe and all over the
world2 and conducts surveys to explore imaging-related manage-
ment of patients.2–4
Methods
The present survey was conducted by the EACVI Scientific Initiative
Committee from 19 December to 28 December 2019 according to the
criteria previously described2–4 (www.escardio.org/eacvi/surveys). A total
of 160 imaging laboratories, mainly based in Europe, were invited to com-
plete an online survey investigating the diagnostic workup and use of
imaging in patients with endocarditis and how these patients are managed
in routine clinical practice. The survey consisted of 20 questions aimed at
understanding the available facilities and workload of each centre, and the
preferred imaging strategy including the use of CT and PET imaging.
Results
In total, 100 (63%) centres from 29 different countries responded to
the survey. Responding centres were located in: Austria (1), Belgium
(4), Croatia (2), Denmark (6), Ecuador (1), Egypt (1), Finland (3),
France (5), Germany (4), Greece (1), Hungary (1), Italy (9), Lebanon
(1), Lithuania (2), North Macedonia (1), Malta (2), Netherlands (5),
New Zealand (1), Norway (16), Poland (2), Portugal (3), Slovenia (6),
Spain (11), Sweden (3), Switzerland (1), Turkey (1), UK (3), and USA
(1). Most centres were tertiary centres or University Hospitals, pro-
viding a high-volume service (30% of centres performed >300 TTE’s
per week whilst only 11% of centres did <_100 TTE’s per week).
Ninety percent of the centres had surgical facilities on site.
The endocarditis team
Sixty-two percent report the use of a specific endocarditis team for
decision-making, while 28% make use of the regular heart team.
When present the endocarditis team comprises a specialist in echo-
cardiography (76%), a cardiac surgeon (63%), a specialist in infectious
disease or microbiology (61%), and a specialist in multi-modality car-
diovascular imaging (57%). Only 27% of centres incorporate a neur-
ologist as part of the endocarditis team (Figure 1).
Echocardiography
TTE and TOE were available at all responding centres, and these
modalities remain the first-line imaging assessments for patients with
suspected endocarditis. In the specific clinical scenarios proposed in
the survey the majority of centres performed both TTE and TOE
imaging, although this varied somewhat depending on the specific
scenario (Figure 2).
In patients with uncomplicated native valve endocarditis confirmed
on TTE, only 14% of responders do not perform further imaging
assessments. Instead, the large majority (90%) of institutions perform
a TOE, and one in 10 centres performed an additional CT (11%) or
PET (12%) scan.
In a patient with a persisting high-level of clinical suspicion of native
valve endocarditis despite no definitive finding on blood cultures or
TTE/TOE, most centres repeated TOE (60%), rather than repeated
TTE (16%).
TOE is the preferred modality to evaluate suspected complica-
tions such as perforations, abscesses, and fistulae and used in 91% of
the centres. Similarly, in patients with a suspected paravalvular leak
complicating mitral valve endocarditis on TTE, most centres (88%)
performed TOE as the next imaging techniques.
With respect to right-sided endocarditis, most centres (56%) per-
formed repeated imaging with TTE in a patient with Staphylococcus
aureus endocarditis of their tricuspid valve and moderate regurgita-
tion, although 35% performed follow-up imaging with TOE.
Figure 1 Bar chart showing the specialists present in the endocarditis team among the centres.





























































































































Patients with a S. aureus bacteraemia but no confirmed diagnosis of
endocarditis undergo an echocardiographic examination in most
centres (92%) at some point during their hospital stay. Almost half of
the centres performed a TTE, while a quarter performed a TTE fol-
lowed by TOE if required. Of interest, 18% performed TOE as the
first diagnostic choice (Figure 3).
Finally, with respect to clinical management, a patient with positive
blood cultures and a 12-14mm vegetation on the native mitral valve
would undergo surgery within 2–3days in 16% of centres and during
their hospital stay in almost half of the institutions (46%). Forty per-
cent would normally perform no surgery if the patient remains stable
without signs of cerebral embolism, heart failure, or uncontrolled
sepsis.
Advanced imaging modalities
The majority of centres have access to advanced nuclear imaging
including PET (69%) and single-photon emission computed
tomography-leucocyte scintigraphy (61%) (Figure 2).
PET is mainly used as a diagnostic tool for prosthesis valve endo-
carditis (75%) or infection of cardiac implantable electronic devices
(71%) when echocardiographic findings are inconclusive.
Furthermore, around 20% of centres use PET if echocardiographic
techniques are inconclusive in patients with suspected native endo-
carditis, or blood culture negative endocarditis. Around one-third of
centres without PET transfer their patients to a nearby PET-centre
for further diagnostic workup. The reason for not transferring
patients were mainly high costs, transfer distance, and in some cases,
the national unavailability of PET imaging (5%).
Almost all centres have CT (94%) available at their site, with 60%
using CT for diagnostic purpose in patients with endocarditis. With
respect to valve evaluation, CT is most often used in patients with
complex prosthetic valve endocarditis (59%). Moreover, CT is used
in a third of centres to assess for perforations, abscesses, and fistulae
in native valve endocarditis when TOE is inconclusive (31%).
Patients with confirmed endocarditis and clinical signs suggestive of
a neurological complication are evaluated for cerebral consequences
with CT as the preferred modality in more than half of centres (57%),
whilst magnetic resonance imaging (MRI) is preferred in a third
(30%). A fifth of centres routinely investigate for cerebral complica-
tions even in absence of neurological symptoms.
When asked how to evaluate the coronary arteries in a 50-year-
old patient with no history of ischaemic heart disease and native valve
endocarditis requiring urgent surgery, the majority of centres (59%)
would use CT coronary angiography, while 30% use invasive angiog-
raphy. Only a minority of (5%) would proceed to the operating the-
atre without further examination of the coronaries.
Discharge and follow-up of patients with
endocarditis
Sixty percent of institutions provide written information about anti-
biotic prophylaxis at discharge, and 30% provide information about
thorough oral hygiene in addition to the verbal discussions with the
medical team upon discharge. However, 34% of centres have no
standardized discharge strategy for patients treated for endocarditis,
with the information provided depending on the attending doctor.
The large majority (91%) of centres provide patient follow-up after
treatment for endocarditis. Fifty-five percent organize clinical and
echocardiographic follow-up within a general cardiology outpatient
clinic, while 29% offer follow-up by dedicated personnel: either by
the endocarditis team or a heart valve specialist. Only a small minor-
ity of centres (9%) do not provide any routine follow-up, but instead,
encourage patients to make recontact if symptoms relapse.
Discussion
The present EACVI survey involved 100 centres from 29 mainly
European countries, and reports on the routine clinical practice and
diagnostic workup of patients with infective endocarditis. Two-thirds
of centres report the use of a specific endocarditis team for decision-
making. Echocardiography holds the first line and central position in
the diagnosis and management of endocarditis. Nuclear imaging
modalities are in fact broadly available among the centres of this sur-
vey and are mainly used in prosthetic valve endocarditis and infection
of cardiac implantable electronic devices. CT is also widely available
and used to assess for structural valve abnormalities, neurological
complications, and to assess the coronary arteries prior to surgery.
The vast majority of institutions provide structured patients follow-
up following hospital discharge.
Figure 2 Bar chart showing the available imaging modalities in the different institutions (multiple choice).


































































































Endocarditis is often a complex disease process, involving multiple
different organ systems. Current guidelines therefore recommend
decision-making by an ‘Endocarditis team’ to encourage a multidiscip-
linary approach to the diagnosis and management of patients with
this condition.1 Indeed application of an endocarditis team approach
has been shown to improve patient outcomes, reducing 1-year mor-
tality in one study.5 In this survey, nearly two-thirds of centres
reported the use of a specific endocarditis team including a specialist
in infectious disease or microbiology. The latter is of increasing im-
portance with growing concerns about antibiotic resistance.
Echocardiography
Echocardiography was used as the first-line diagnostic approach in all
the specific clinical scenarios detailed in this survey. This is consistent
with the guidelines.1
In patients with uncomplicated native valve endocarditis confirmed
with TTE, the large majority (90%) of institutions would still proceed
with a TOE for further diagnostic workup. TTE is a highly specific test
(specificity 90% similar to TOE), and whilst its sensitivity for the diag-
nosis of endocarditis has improved (70%), it remains relatively in-
sensitive for associated structural complications. For example, the
sensitivity of TTE for abscess formation is 50% compared to 90% for
TOE.6,7 The high rate of follow-up TOE imaging following a positive
TTE scan for native valve endocarditis is therefore understandable
and in harmony with the current guideline recommendations.1
Almost all centres would perform repeat imaging in patients with
an initially negative examination and a sustained clinical high level of
suspicion of an endocarditis. The majority would proceed with echo-
cardiography, 60% and 16% would repeat TOE and TTE, respectively,
in accordance with the current guidelines.1 In patients with right-
sided endocarditis, follow-up imaging is more commonly performed
with TTE (56%) although a third would use TOE. TTE usually allows
detailed assessment of the tricuspid valve and right ventricle, whilst
TOE is more sensitive for pulmonary- and left-sided valve
involvement.
Echocardiography is recommended by the current guidelines in
patients with S. aureus bacteraemia in view of the high frequency of
endocarditis in such cases and because of the high morbidity and
mortality of S. aureus endocarditis.1 Consistent with this guideline the
majority of centres would perform echocardiography in these
patients.
Embolic events have potentially devastating clinical consequences.
With rapid diagnosis, initiation of antibiotics and surgery these effects
can be minimized. The risk of embolism increases with vegetations
>10mm, although risk stratification remains difficult and surgery is
also associated with risk. The exact role of emergency surgery in
patients with large vegetations remains controversial. The guidelines
provide a Class I level B indication for surgery in patients with a vege-
tation >10mm and one or more embolic events.1 In our scenario,
where the patients had a large vegetation but no clear history of em-
bolism, there was variation in practice: 46% of centres would perform
surgery during the hospital stay; one-third within 2–3days; whereas
40% would not perform surgery in a stable patient.
The clinical use of advanced imaging
techniques
Even though echocardiography remains critical to diagnosis and man-
agement of endocarditis the use of other imaging modalities such as
CT and PET appears to be increasing. In this survey, almost all centres
had access to CT and most centres had access to advanced nuclear
techniques.
Figure 3 Pie chart showing that most centres perform echocardiographic examinations during a hospital stay in patients with a Staphylococcus aur-
eus bacteraemia/sepsis.












































































































































Consistent with the guidelines, PET imaging is mainly used in the
diagnostic work-up of patients with prosthetic endocarditis including
graft infections (75%) and infection of cardiac implantable electronic
devices (71%) when TTE/TOE findings are negative or doubtful.
CT was also used to assess patients with complex prosthetic valve
endocarditis and more generally to detect structural complications of
endocarditis (abscesses/pseudoaneurysms, fistulae, etc.) where these
are suspected complications and TOE is inconclusive. A trend also
commented in the current guidelines.1
CT is also used widely to assess for neurological complications and
to investigate the coronary arteries in young patients being consid-
ered for endocarditis surgery. Fifteen to 30% of patients with endo-
carditis get symptomatic neurological complications, whereas up to
60% have additional clinically silent cerebral embolisms.8,9 A neuro-
logical event may affect the indication of surgery and thereby the
management. As expected, most centres evaluate patients with
neurological symptoms for cerebral embolism. Of interest, 21%
assessed patients for cerebral lesions regardless of neurological
symptoms. MRI is also used to assess for neurological complications.
It has a higher sensitivity compared to CT but is harder and less feas-
ible to get an urgent MRI scan in clinical practice. This was reflected in
the survey.
Invasive angiography, with a potential risk of complications, has
traditionally been used to access the coronaries before surgery.1
However, CT represents an attractive diagnostic alternative in
younger patients, indeed, the majority of centres in this survey would
use CT coronary angiography in this situation.
Follow-up of survivors of endocarditis
Although the risk of recurrence among endocarditis survivors is rela-
tively low (2–6%), patient education and follow-up is important to re-
duce the risk of relapse and to monitor for potential complications of
the index infection. More than half of the centres provided standar-
dized discharge information, with additional written material. This
will improve patient education and may increase adherence to advise.
Limitations
Most respondents were from tertiary centres or university hospitals
with a high volume of patients, and the findings of this survey may
therefore not be generalizable to other clinical environments.
Conclusions
In Europe, a relatively homogenous adherence to current recom-
mendation was observed for most diagnostic and management
including the follow-up of patients with endocarditis. Decision-
making is most commonly performed by a multidisciplinary team
including a specialist in infectious diseases or microbiology.
Echocardiography (TTE and TOE) remains the first line and central
imaging modality for patient diagnosis and assessment, but 60% of
centres also commonly use CT, whilst PET imaging is used to investi-
gate patients with prosthetic valve endocarditis or device infection
where diagnostic uncertainty persists.
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